Pulmongene
PrivateCompany Overview
Pulmongene operates in Healthcare & Life Sciences and is based in Beijing. It was founded in 2019.
Pulmongene is a clinical-stage biotechnology company that develops first-in-class therapies for pulmonary, fibrotic, and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pulmongene Comparables
Compare Pulmongene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Celea Therapeutics | 83% | |
| Endeavor BioMedicines | 83% | |
| Oorja Bio, Inc. | 80% |
For institutional investors. Book with your work email.
Pulmongene Funding Rounds
Historical fundraising activity
Pulmongene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pulmongene's valuation, stock price, and market status.
Is Pulmongene a public or private company?
Pulmongene is a private company.
What is the current stock price of Pulmongene?
Pulmongene is a private company, so its shares have no public market price. Caplight tracks Pulmongene's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pulmongene worth (valuation)?
Valuation information for Pulmongene is not publicly available.
Can I buy Pulmongene stock?
Pulmongene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pulmongene's last funding round?
Funding round information for Pulmongene is not publicly available.
Who are the main investors in Pulmongene?
Investor information for Pulmongene is not publicly disclosed.
Will Pulmongene IPO soon?
No public IPO plans have been announced for Pulmongene.
How can I track Pulmongene secondary market activity?
Caplight tracks bids, offers, and trades in Pulmongene's shares on secondary markets.